Internal Medicine, Gastroenterology · Wooster, OH
NPI
1841270766
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
128 E Milltown Rd, Ste 206
Wooster, OH, 44691
Phone (330) 263-7372
Medicare paid, 2024
$59K
681 services
Medicare patients, 2024
388
Average age 73
Drug cost, 2024
$642K
1,631 prescriptions
Company payments, 2025
$2,401
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vincent F Jabour was code 99203 (office e&m - new), 120 times for 120 patients. In total Vincent F Jabour billed 681 services in 21 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99203 Office E&M - New | Office | 120 | 120 | $69.16 | $8,299 |
| 99214 Office E&M - Established | Office | 106 | 94 | $79.73 | $8,451 |
| 99202 Office E&M - New | Office | 96 | 96 | $37.37 | $3,588 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 81 | 81 | $162.65 | $13K |
| 43239 Upper GI Endoscopy | Facility | 60 | 59 | $73.02 | $4,381 |
| 45380 Lower GI Endoscopy - Other | Facility | 55 | 55 | $94.37 | $5,190 |
| 99213 Office E&M - Established | Office | 44 | 41 | $44.24 | $1,947 |
| 45385 Colonoscopy - Lesion Removal | Facility | 32 | 32 | $156.00 | $4,992 |
| 99204 Office E&M - New | Office | 26 | 26 | $109.04 | $2,835 |
| 45378 Lower GI Endoscopy - Other | Facility | 16 | 16 | $121.99 | $1,952 |
| 43249 Upper GI Endoscopy | Facility | 12 | 11 | $108.13 | $1,298 |
By year: 2022 $72K for 723 services; 2023 $66K for 693 services; 2024 $59K for 681 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vincent F Jabour prescribed most often to Medicare patients was Pantoprazole Sodium, with 554 prescriptions and refills. In total Vincent F Jabour wrote 1,631 Medicare prescriptions that cost $642K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 554 | 1,010 | 126 | $5,213 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 104 | 105 | 102 | $17K |
| Rabeprazole Sodium Generic | 85 | 103 | 31 | $2,098 |
| Omeprazole Generic | 84 | 185 | 24 | $836 |
| Balsalazide Disodium Generic | 60 | 101 | Under 11 | $9,155 |
| Linzess Linaclotide | 58 | 72 | 18 | $37K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 45 | 45 | 45 | $2,954 |
| Mesalamine Generic | 38 | 65 | Under 11 | $16K |
| Ursodiol Generic | 37 | 55 | Under 11 | $8,204 |
| Azathioprine Generic | 33 | 72 | Under 11 | $1,908 |
| Trulance Plecanatide | 32 | 52 | Under 11 | $28K |
| Xifaxan Rifaximin | 32 | 32 | Under 11 | $92K |
| Lansoprazole Generic | 29 | 49 | Under 11 | $767 |
| Carvedilol Generic | 28 | 35 | Under 11 | $164 |
| Lubiprostone Generic | 26 | 36 | Under 11 | $3,364 |
Brand drugs: - claims; generic drugs: 1,292 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vincent F Jabour $2,401 ($2,401 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $508.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $508 |
| Janssen Biotech, Inc. JNJ | 15 | $395 |
| Genzyme Corporation SNY | 9 | $201 |
| Gilead Sciences, Inc. GILD | 13 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $172 |
| Ardelyx, Inc. ARDX | 5 | $164 |
| QOL Medical, LLC | 9 | $141 |
| Phathom Pharmaceuticals, Inc. PHAT | 10 | $140 |
| Lilly USA, LLC LLY | 5 | $99.34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $81.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.